There is no evidence that vasectomy leads to significant health problems, making it unlikely that the Urology Nevada patient who took the life of one urologist and injured another was suffering from the effects of “botched” surgery, say two urologists who are experts in vasectomy.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to a recent study.
Preoperative hypoalbuminemia is a risk factor for complications following radical cystectomy, say researchers from the University of North Carolina, Chapel Hill.
In men with nonobstructive azoospermia, frozen and fresh testicular sperm offer similar fertilization and pregnancy rates, according to the authors of a meta-analysis who say it is the first such study to specifically address the fresh-versus-frozen debate in this population.
A battle is brewing in California between trial lawyers and physicians, one that could be a harbinger of things to come nationally.
Urologists across the country offer their opinions on high-intensity focused ultrasound.
Thoughtful policies-with the input of physicians and physician specialty expertise-should be enacted to successfully address inappropriate utilization and ensure more efficient pathways.
Men who walked at a fast pace prior to prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer.
Patients with chronic kidney disease who undergo robot-assisted partial nephrectomy for kidney cancer have minimal loss of renal function-a smaller amount even than patients with normal kidney function, according to researchers at Henry Ford Hospital in Detroit, who say their study is the largest of its kind.
Type of surgical approach-open or robot assisted-appears to have no effect on specific clinical outcomes in patients undergoing radical prostatectomy for high-risk prostate cancer, nor does the procedure influence the pathway subsequent therapy might follow, according to a recent study.
Results from a survey of members of the Society of University Urologists (SUU) highlight the current work force shortage in academic urology and provide information that is instructive for both academicians and urologists-in-training who are planning their career, said Joshua Langston, MD, at the 2013 American College of Surgeons Clinical Congress in Washington.
More than 85% of patients undergoing robot-assisted laparoscopic prostatectomy may not require opioid analgesia either immediately post-op, in hospital, or upon release, according to a recent study.
A recently published study found that a small percentage of men who seek infertility treatment are potentially hurting their ability to have children by taking testosterone supplements.
Urologist Daniel Shames, MD, has had a unique and varied career, with stops in clinical practice, the FDA, and his current role as a consultant to the pharmaceutical industry. Dr. Shames’ wide-ranging experience brings an insightful perspective on the topics he discusses in this interview: what goes into FDA drug approvals, quality of life endpoints, and the Sunshine Act.
This question points out the importance of understanding each description as you select the appropriate code for services provided.
As all too often is the case, the feds can’t just stop with implementing the law in a common sense way; they seem to take it to an extreme.
I certainly applaud the authors’ efforts and feel that such standardized algorithms can be very beneficial for practicing urologists. However, their study lacks an objective measure of pain (such as a Likert pain score) or explanation of why many of the patients did require narcotics.
In this article, I will try to clarify the differences among the Stage 2 measures in terms of what is required to fulfill each one.
As you start to prepare paperwork for your accountant, be aware of the changes relative to your 2013 tax return, which has a filing deadline of April 15, 2014.
A lawsuit was filed against both the urologist and the radiologist involved in the treatment of the kidney stone, claiming that he was not informed of the abnormality on the left kidney noted on the CT scan and the recommendation for follow-up.
Although testosterone use has increased significantly among older men in the past decade, many patients appear to have normal testosterone levels and do not meet the clinical guidelines for treatment, according to new research.
The claim that a “botched” vasectomy left Urology Nevada shooter Alan Frazier in poor health has no basis, according to the practice.
Both the death rate and incidence rate for prostate cancer continues to decline, according to the latest round of statistics from leading U.S. cancer groups.
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington in Seattle have developed a personalized tool that they say can predict the likelihood of prostate cancer overdiagnosis.
Residency is tough. Despite my chairman’s admonition that everything a resident needs to know is in “Campbell-Walsh Urology,” the text is missing at least one lesson, namely, how to find a job.
PSA screening has likely played an important role in the 40%-plus drop in prostate cancer mortality since the late 1980s, although the mortality rate for metastatic disease has remained the same, say study authors from the University of California, Davis.
The controversial oil and natural gas drilling technique called hydraulic fracturing, or fracking, uses many chemicals that can disrupt the body’s hormones, according to new research.
About two-thirds of urologists own electronic prescribing systems, placing urology second among specialties in e-prescribing adoption, according to a study that tracked adoption rates between 2007 and 2010.
Signs of inflammation in a man’s prostate biopsy may indicate that he has a reduced risk of subsequently being diagnosed with prostate cancer in a future biopsy, according to the authors of a recently published study.
Insurance coverage has expanded for an epigenetic test for prostate cancer and percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB).